(NASDAQ: HSIC) Henry Schein's forecast annual revenue growth rate of 3.21% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 7.91%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.
Henry Schein's revenue in 2025 is $12,673,000,000.On average, 9 Wall Street analysts forecast HSIC's revenue for 2025 to be $1,613,861,423,261, with the lowest HSIC revenue forecast at $1,605,096,653,528, and the highest HSIC revenue forecast at $1,626,554,401,285. On average, 9 Wall Street analysts forecast HSIC's revenue for 2026 to be $1,670,384,334,614, with the lowest HSIC revenue forecast at $1,657,635,849,569, and the highest HSIC revenue forecast at $1,697,546,266,982.
In 2027, HSIC is forecast to generate $1,730,873,700,705 in revenue, with the lowest revenue forecast at $1,699,731,778,328 and the highest revenue forecast at $1,770,698,808,670.